S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Pieris Pharmaceuticals (PIRS) News Today

$0.14
-0.01 (-6.45%)
(As of 04/19/2024 ET)
SourceHeadline
MarketBeat logoStockNews.com Initiates Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS)
americanbankingnews.com - April 13 at 2:22 AM
msn.com logoAvalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M
msn.com - April 1 at 3:29 AM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
finanznachrichten.de - March 28 at 2:48 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
finance.yahoo.com - March 27 at 8:11 AM
finance.yahoo.com logoPIRS Apr 2024 2.500 call
finance.yahoo.com - March 19 at 8:35 PM
investing.com logoPieris Pharmaceuticals Inc (PIRS)
investing.com - February 10 at 8:42 PM
finance.yahoo.com logoPieris Pharmaceuticals, Inc. (PIRS)
finance.yahoo.com - February 1 at 6:10 PM
finance.yahoo.com logoInvestors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
finance.yahoo.com - December 18 at 7:48 AM
investing.com logoPieris Pharmaceuticals Inc (PIRS) Earnings Dates & Reports
investing.com - November 20 at 1:26 PM
morningstar.com logoPieris Pharmaceuticals Inc PIRS
morningstar.com - November 4 at 1:54 AM
finance.yahoo.com logoPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - September 25 at 2:43 PM
finance.yahoo.com logoIs Pieris Pharmaceuticals (PIRS) a Value Trap? A Comprehensive Analysis
finance.yahoo.com - August 24 at 5:19 PM
finance.yahoo.com logoPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's What You Should Know
finance.yahoo.com - August 23 at 5:43 PM
msn.com logoPieris (PIRS) Up On Receiving Milestone Payment From Partner
msn.com - August 18 at 5:30 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
finance.yahoo.com - August 17 at 8:30 AM
finance.yahoo.com logoPieris (PIRS) Pursues Strategic Alternatives, Stock Rises
finance.yahoo.com - July 19 at 2:41 PM
markets.businessinsider.com logoPieris Pharma Cuts Around 70% Workforce; Plans Strategic Options
markets.businessinsider.com - July 19 at 9:41 AM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
finanznachrichten.de - July 18 at 2:07 PM
finance.yahoo.com logoWhy Pieris Pharmaceuticals Shares Shooting Higher Today?
finance.yahoo.com - July 18 at 2:07 PM
finance.yahoo.com logoPieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
finance.yahoo.com - July 18 at 2:07 PM
marketbeat.com logo
marketbeat.com - July 18 at 9:11 AM
fool.com logoPieris Pharmaceuticals (NASDAQ: PIRS)
fool.com - July 13 at 5:56 PM
msn.com logoWhy Are Pieris Pharmaceuticals Shares Tanking Today
msn.com - June 21 at 2:19 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
finance.yahoo.com - June 21 at 9:16 AM
marketbeat.com logo
marketbeat.com - June 21 at 6:55 AM
finance.yahoo.com logoWe're A Little Worried About Pieris Pharmaceuticals' (NASDAQ:PIRS) Cash Burn Rate
finance.yahoo.com - June 11 at 1:05 PM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
finanznachrichten.de - June 2 at 6:13 PM
finance.yahoo.com logoPieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
finance.yahoo.com - June 2 at 6:13 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
finance.yahoo.com - May 22 at 9:22 AM
finance.yahoo.com logoPieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference
finance.yahoo.com - May 21 at 8:56 AM
finance.yahoo.com logoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Analysts Just Cut Their EPS Forecasts Substantially
finance.yahoo.com - May 15 at 8:25 AM
seekingalpha.com logoPieris Pharmaceuticals GAAP EPS of -$0.18 misses by $0.04, revenue of $1.94M misses by $4.57M
seekingalpha.com - May 12 at 12:35 AM
finance.yahoo.com logoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript
finance.yahoo.com - May 11 at 2:34 PM
msn.com logoRecap: Pieris Pharmaceuticals Q1 Earnings
msn.com - May 10 at 1:30 PM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
finanznachrichten.de - May 10 at 8:29 AM
finance.yahoo.com logoPieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
finance.yahoo.com - May 10 at 8:29 AM
msn.com logoPreview: Pieris Pharmaceuticals's Earnings
msn.com - May 9 at 5:24 PM
finance.yahoo.com logoPieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shares Lagging The Industry But So Is The Business
finance.yahoo.com - May 5 at 9:15 AM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep
finanznachrichten.de - May 4 at 1:04 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep (PRS-060/AZD1402)
finance.yahoo.com - May 4 at 1:04 PM
finance.yahoo.com logoPieris Pharmaceuticals to Host First Quarter 2023 Investor Call and Provide Corporate Update on May 10, 2023
finance.yahoo.com - May 2 at 6:11 PM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa At 2023 AACR Annual Meeting
finanznachrichten.de - April 17 at 5:19 PM
finance.yahoo.com logoPieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
finance.yahoo.com - April 17 at 5:19 PM
finance.yahoo.com logoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript
finance.yahoo.com - April 1 at 4:32 PM
finance.yahoo.com logoPieris Pharmaceuticals Full Year 2022 Earnings: US$0.45 loss per share (vs US$0.71 loss in FY 2021)
finance.yahoo.com - March 31 at 10:29 AM
benzinga.com logoPieris Pharmaceuticals Clocks 17.6% YoY Revenue Decline In FY22 To $25.9M
benzinga.com - March 29 at 12:45 PM
finance.yahoo.com logoPieris Pharmaceuticals (PIRS) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 29 at 12:45 PM
finanznachrichten.de logoPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports Full-Year 2022 Financial Results and Business Updates
finanznachrichten.de - March 29 at 7:45 AM
finance.yahoo.com logoPieris Pharmaceuticals Reports Full-Year 2022 Financial Results and Business Updates
finance.yahoo.com - March 29 at 7:45 AM
markets.businessinsider.com logoPieris Pharmaceuticals earnings: here's what Wall Street expects
markets.businessinsider.com - March 28 at 10:19 AM
Get Pieris Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PIRS and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

PIRS Media Mentions By Week

PIRS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PIRS
News Sentiment

0.00

0.51

Average
Medical
News Sentiment

PIRS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PIRS Articles
This Week

2

0

PIRS Articles
Average Week

Get Pieris Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PIRS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PIRS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners